NCT07110194 2025-08-07Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological MalignanciesChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Not yet recruiting75 enrolled